Psyence Biomedical Ltd Asset Turnover Ratio (PBM), as of second quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Psyence Biomedical ltd   (NASDAQ: PBM)
 

Psyence Biomedical Ltd Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Sep 30 2025, Psyence Biomedical Ltd has not recorded any assets.
Visit Psyence Biomedical Ltd Balance sheet

Within sector 239 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2025 compared to the preceding quarter from to 3997.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PBM Asset Turnover Ratio (Sep 30 2025)
II. Quarter		 (Mar 31 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter
Y / Y Asset Change 727.61 % 372.68 % 128.8 % 217.8 % 128.8 %
Y / Y Revenue Change - -20 % - - -
Asset Turnover Ratio (TTM) - 0 - - -
PBM's Total Ranking # 3997 # # # #
Seq. Asset Change 75.09 % 372.68 % -43.75 % 77.78 % 0 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 240
Healthcare Sector # 619
Overall Market # 3997

Asset Turnover Ratio Statistics
High Average Low
0 0 0
(Jan 31 2023)   (Jan 31 2022)




PBM Company Profile • Back to PBM Efficiency Comparisons • Compare PBM Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2025 Assets at quarter ending Sep 30 2025
Altimmune inc 0.00 $ 0.020  Millions$ 176.342  Millions
Lyell Immunopharma Inc 0.00 $ 0.041  Millions$ 428.519  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.